Log In
Print this Print this

Patrome (Rytary) (GSK587124, IPX066)

Also known as: second generation carbidopa/levodopa

  Manage Alerts
Collapse Summary General Information
Company Impax Laboratories Inc.
DescriptionExtended-release combination of carbidopa and levodopa
Molecular Target Not available
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentApproved
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat advanced Parkinson's disease (PD); Treat idiopathic Parkinson's disease (PD); Treat Parkinson's disease (PD)
Regulatory Designation U.S. - Special Protocol Assessment (Treat Parkinson's disease (PD));
U.S. - Undisclosed Review (Treat idiopathic Parkinson's disease (PD));
EU - Standard Review (Treat idiopathic Parkinson's disease (PD))

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today